13D/13G Filings - Entrada Therapeutics Inc. (TRDA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-11-12
4:30 pm
Purchase
2021-11-0213DEntrada Therapeutics, Inc.
TRDA
5AM Ventures V L.P.4,409,687
14.800%
4,409,687increase
(New Position)
Filing
History
2021-11-12
4:07 pm
Purchase
2021-11-0213DEntrada Therapeutics, Inc.
TRDA
MPM BioVentures 2014, L.P. 4,427,092
14.800%
4,427,092increase
(New Position)
Filing
History
2021-11-10
4:50 pm
Purchase
2021-11-0213GEntrada Therapeutics, Inc.
TRDA
BAKER BROS. ADVISORS LP4,704,419
15.100%
4,704,419increase
(New Position)
Filing
History
Goto Prev, 0, 1